BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21150074)

  • 1. Stroke after intravenous gamma globulin.
    Saeed F; Siddiqi NF; Dorairaj K; Laurence TN
    Neurol India; 2010; 58(6):960-2. PubMed ID: 21150074
    [No Abstract]   [Full Text] [Related]  

  • 2. Retinal vein occlusion following intravenous immunoglobulin treatment.
    Nawasiwatte BM; Somaratne SC; Fernando A; Gunaratne PS
    Ceylon Med J; 2012 Dec; 57(4):170-1. PubMed ID: 23292061
    [No Abstract]   [Full Text] [Related]  

  • 3. Anaphylaxis with intravenous immunoglobulin: a time for introspection.
    Jain RS; Agrawal R; Kumar S; Gupta PK
    Am J Emerg Med; 2015 Sep; 33(9):1332.e1-2. PubMed ID: 25819200
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome.
    Doss-Esper CE; Singhal AB; Smith MS; Henderson GV
    J Neuroimaging; 2005 Apr; 15(2):188-92. PubMed ID: 15746232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute generalized exanthematous pustulosis following intravenous immunoglobulin.
    Moon SH; Shin MK
    Indian J Dermatol Venereol Leprol; 2012; 78(6):774. PubMed ID: 23075659
    [No Abstract]   [Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome.
    Koichihara R; Hamano S; Yamashita S; Tanaka M
    Pediatr Neurol; 2008 Aug; 39(2):123-5. PubMed ID: 18639758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual patients who experienced both Guillain-Barré syndrome and CIDP.
    Kuitwaard K; van der Pol WL; Ruts L; van Doorn PA
    J Peripher Nerv Syst; 2009 Mar; 14(1):66-8. PubMed ID: 19335542
    [No Abstract]   [Full Text] [Related]  

  • 8. Unraveling Guillain-Barré syndrome.
    Castro MC
    Nurs Manage; 2010 Aug; 41(8):36-9; quiz 39-40. PubMed ID: 20671533
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent Guillain-Barre syndrome as a complication of immune reconstitution in HIV.
    Makela P; Howe L; Glover S; Ferguson I; Pinto A; Gompels M
    J Infect; 2002 Jan; 44(1):47-9. PubMed ID: 11972420
    [No Abstract]   [Full Text] [Related]  

  • 10. Guillain-Barré syndrome in elderly people.
    Leung SS
    J Am Geriatr Soc; 2008 Feb; 56(2):381-2. PubMed ID: 18251836
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
    Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
    Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side effects of combined therapy of methylprednisolone and intravenous immunoglobulin in Guillain-Barré syndrome.
    Odaka M; Tatsumoto M; Hoshiyama E; Hirata K; Yuki N
    Eur Neurol; 2005; 53(4):194-6. PubMed ID: 15970631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse effects of intravenous human polyvalent immunoglobulins].
    Chapuis C; Guy N; Besson G
    Rev Neurol (Paris); 2008 Sep; 164 Spec No 3():F203-10. PubMed ID: 18992580
    [No Abstract]   [Full Text] [Related]  

  • 14. [Case of herpes zoster associated Guillain-Barré syndrome with a relapse of eruptions after intravenous immunoglobulin therapy].
    Nagane Y; Utsugisawa K; Obara D
    Rinsho Shinkeigaku; 2006 Sep; 46(9):664-7. PubMed ID: 17260813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IVIG--a hemolytic culprit.
    Pintova S; Bhardwaj AS; Aledort LM
    N Engl J Med; 2012 Sep; 367(10):974-6. PubMed ID: 22931280
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous Guillain-Barré syndrome and acute disseminated encephalomyelitis in the pediatric population.
    Bernard G; Riou E; Rosenblatt B; Dilenge ME; Poulin C
    J Child Neurol; 2008 Jul; 23(7):752-7. PubMed ID: 18354151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset seropositive Isaacs' syndrome after Guillain-Barré syndrome.
    Myers KA; Baker SK
    Neuromuscul Disord; 2009 Apr; 19(4):288-90. PubMed ID: 19303775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis.
    Prescrire Int; 2000 Oct; 9(49):142-3. PubMed ID: 11603414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible focal encephalic abnormalities in a patient with Guillain-Barré syndrome.
    Cruto CA; Pinto NC; Pato MV
    Arq Neuropsiquiatr; 2012 Jun; 70(6):471-2. PubMed ID: 22699548
    [No Abstract]   [Full Text] [Related]  

  • 20. A rare form of Guillain-Barré syndrome: pharyngeal-cervical-brachial variant.
    Hergüner MO; Tepe T; Altunbaşak S; Baytok V
    Turk J Pediatr; 2008; 50(1):91-3. PubMed ID: 18365602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.